Dr.Reddy'S Laboratories, Inc.

BIORPHEN

Manufacturer:

Dr.Reddy'S Laboratories, Inc.

Biorphen HCPCS:

J2372

HCPCS Code Descriptor:

Injection, phenylephrine hydrochloride (biorphen), 20 micrograms

Category:

J Code

Biorphen NDCs:

43598-0172-15

Primary Type:

Cardiology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

43598-0172-15

About Biorphen:

BIORPHEN is a Cardiology drug manufactured by Dr.Reddy'S Laboratories, Inc. and administered via the Intravenous route of administration. The J Code: J2372 is aligned to the drug BIORPHEN.

BIORPHEN belongs to the class of drugs known as alpha-1 adrenergic agonist. This medication is used to help treat low blood pressure that is the result of the dilation of blood vessels in the body. This HCPCS Code (J2372) is manufactured by Dr.Reddy's Laboratories is separate from the generic BIORPHEN HCPCS Code: J2370. The Dr.Reddy’s J2372 BIORPHEN HCPCS was approved under the 505(b)(2) pathway.

ACCESS PRICING AND MORE BY REGISTERING

J2372 Added Date:

July 1, 2023

J2372 Effective Date:

July 1, 2023

J2372 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Biorphen billing and coding information.
Our team did not identify a source for Biorphen patient assistance information. Please reach out to our team if you feel that this is a mistake.
BIORPHEN prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BIORPHEN. Please check back in a few weeks.